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Summary. Recent advancement in technology has lead to a wide range of genetic and biologi-
cal markers that hold great potential in improving the prediction of survival outcomes. Although
such new markers promise better disease prognosis, the accuracy in identifying short term and
long term survivors remains unsatisfactory for most complex diseases. It has often been ar-
gued that short term clinical outcomes may have potential in predicting long term outcomes. In
this paper, we propose to develop and evaluate conditional prognostic rules for the prediction
of long term outcomes based on baseline marker information along with short term outcome
status at an earlier landmark time. When there are multiple markers available, we construct an
optimal composite score by fitting a proportional hazards working model for the conditional sur-
vival distribution. We also provide inference procedures for evaluating the incremental value of
new markers in landmark prediction. The accuracy of the score is evaluated non-parametrically
based on inverse probability weighting. Resampling procedures are proposed to derive esti-
mation procedures for the accuracy measures. With a real example and numerical studies, we
demonstrate that the proposed procedures perform well in finite samples.
Keywords: biomarkers, disease prognosis, predictive accuracy, risk prediction, survival anal-
ysis.
1. Introduction
In studies designed to develop prognostic classifiers based on predictive markers, marker
measurements are often ascertained at baseline and patients are followed over time for the
occurrence of certain clinical conditions or death. Since the risk for the disease occurrence
may change over time, the time domain must be incorporated when developing prognostic
rules. When there are multiple markers available to assist in prediction, it is of clinical
interest to construct an optimal prognostic index based on available marker information.
In the standard diagnostic setting with binary outcomes, various procedures have been
proposed to combine multiple markers to improve diagnostic accuracy (Su and Liu, 1993;
Pepe and Thompson, 2000; McIntosh and Pepe, 2002; Pepe et al., 2005). For event time
outcomes, the most popular approach to combine markers for predicting time to disease
onset is to fit the Cox proportional hazards model,
λ(t | Z) = λ0(t) exp{β′Z},
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and use β̂
′
Z for prediction, where λ(t | Z) is the hazard function for a subject with marker
value Z, λ0(·) is some unknown baseline hazard function, and β̂ is the maximum partial
likelihood estimate of β (Kalbfleisch and Prentice, 2002). For example, the Framingham
Risk Score (Wilson et al., 1998) for predicting cardiovascular failure was constructed based
on such a method. Recently, Zheng et al. (2006) and Cai and Cheng (2008) showed that
when the Cox model fails to hold, the risk score β̂
′
Z may have poor accuracy in discrim-
inating subjects with T ≤ t from those with T > t for some t. To improve the prediction
accuracy, Zheng et al. (2006) and Uno et al. (2007) proposed the use of time-varying coef-
ficient models which allow for different composite scores for predicting short term and long
term survival.
In general, patient populations may be heterogenous and represent a mixture of different
subtypes of disease. As such, subjects with similar clinical symptoms may have drastically
different disease outcomes. For example, breast cancer patients sharing the same clinical
features, such as lymph node status and histological grade, may have significantly different
survival profiles. Recent advancement in technology has lead to a wide range of genetic
and biological markers that hold great potential in improving the prediction of survival
outcomes. In a recent breast cancer gene expression study, van’t Veer et al. (2002) and van
de Vijver et al. (2002) developed a gene score for prognosis based on a 70-gene profile. The
inclusion of the gene score was shown to have improved the prognostic accuracy over the
traditional clinical markers in predicting survival (Uno et al., 2007). Although such new
classifiers promise better disease prognosis, the accuracy in identifying short term vs. long
term survivors remains unsatisfactory for most complex diseases. It has been often argued
that short term clinical outcomes may have potential in predicting long term survival.
For example, van der Sluis et al. (1997) studied the extent to which short-term outcomes
can predict long-term outcomes for pediatric polytrauma patients. Weisner et al. (2003)
demonstrated a clear association between short-term and long-term treatment success for
alcohol addiction. To optimally select prevention and treatment strategy, it would be of
great interest to develop comprehensive prognostic systems for patients that could make
prediction about both the short term survival and the long term survival given the short
term outcome. Such evaluations provide a more complete picture of the long term trajectory
of disease progression and thus can be helpful for patients to make risk benefit decisions.
In this paper, we propose to develop conditional prognostic rules for the prediction of
long term outcomes based on baseline marker information along with short term outcome.
When the short term and long term outcomes are the same clinical event, Van Houwelingen
http://biostats.bepress.com/harvardbiostat/paper123
Landmark Prediction of Survival 3
(2007) proposed robust estimation procedures for regression coefficients under a propor-
tional hazards landmark prediction model. Here, we propose to extend the procedures
given in Van Houwelingen (2007) for the setting where the short term outcome is based on
an intermediate event that may be different from the event of interest for the long term
outcome. For example, when selecting treatment options for breast cancer patients, it may
be helpful to provide the chance of long term survival with and without conditioning on
information regarding the short term outcome of distant metastasis-free survival. On the
other hand, growing evidence suggests that complex gene and environment interactions un-
derlie a number of diseases (Hunter, 2005). While developing such prediction models, it
is crucial to realize that most simplistic statistical models are unlikely to capture the true
relationship between the event times and the predictors of interest. We propose robust in-
ference procedures for making inference about model parameters without requiring correct
specification of the model. In addition, we propose non-parametric model free procedures
to assess the prediction performance of the risk score obtained from the landmark models.
Procedures for evaluating the incremental value of new markers for landmark prediction are
also derived. Simulation studies suggest that the proposed inference procedures perform
well in finite sample and prediction rules obtained based on the robust landmark model out-
perform those derived from a global Cox model when the underlying patient populations
are heterogeneous. Our procedures are illustrated using a breast cancer gene expression
study.
2. Evaluating Conditional Prognostic Rules
Let TL denote event time for the long term outcome and T ∗S denote the event time for
the short term outcome, which may or may not be the same as TL. For example, TL may
represent time to death and T ∗S may represent time to distant metastasis. Due to the
potential difference in the underlying disease process, patients who have a good short term
outcome may have very different clinical outcomes from the general patient population. It
is thus of interest to incorporate information on the short term outcome into the prediction
of long term outcomes. Here, we are particularly interested in the prediction of TL among
subjects with a good short term outcome, defined as Ωt0 = {T ∗S > t0, TL > t0} = {TS > t0},
where TS = min(T ∗S , TL). Such a rule could be used to distinguish subjects who will fail
within τ years since t0 from those who will survive τ + t0 years among Ωt0 , where pr(XL >
τ + t0, XS > t0) > 0. Note that the classification of TL > τ + t0 for subjects in Ωt0 is
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equivalent to the classification of whether the residual life Rt0L = TL − t0 is greater than τ .
Let Z denote the p× 1 vector of predictors measured at baseline and let Zη = η(Z) denote
the composite score based on Z for predicting the long term outcome: Dt0+τL = I(TL ≤
τ + t0) = I(Rt0L ≤ τ).
For any given score Zη, one may evaluate its potential in predicting DτL by extending
various time-specific accuracy measures as suggested in the literature (Heagerty et al., 2000;
Cai et al., 2006; Uno et al., 2007; Cai and Cheng, 2008) to incorporate the conditional prog-
nosis given TS > t0. For example, the discrimination accuracy of Zη for classifying Dt0+τL
among Ωt0 can be summarized by the time-specific sensitivity and specificity functions:
Senst0,τ (c) = prΩt0 (Zη > c | D
t0+τ
L = 1), and Spect0,τ (c) = prΩt0 (Zη < c | D
t0+τ
L = 0)
where prΩt0 represents the probability taken over the sub-population in Ωt0 . To adequately
summarize the inherent discrimination accuracy for a score, Senst0,τ (·) and Spect0,τ (·)
must be considered simultaneously since higher values of Senst0,τ (·), obtained by low-
ering the threshold, are achieved at the expense of decreasing the Spect0,τ (·). A com-
monly used technique for summarizing the trade-offs between the sensitivity and speci-
ficity is the Receiver Operating Characteristic (ROC) curve (Swets and Pickett, 1982;
Hanley, 1989; Begg, 1991). The time-specific ROC curve can be defined as a plot of:
{1− Spect0,τ (c),Senst0,τ (c), c ∈ (−∞,∞)}, or, equivalently, the function {u,ROCt0,τ (u) =
Senst0,τ (Spec
−1
t0,τ (1 − u)), u ∈ (0, 1)}. The overall accuracy of Zη is often summarized by
the area under the ROC curve (AUC), AUCt0,τ =
∫
ROCt0,τ (u)du.
These classification accuracy measures are useful for describing the inherent capacity a
score has in discriminating DtL and thus for identifying optimal scoring systems and devel-
oping rules for assigning subjects into good or poor prognostic groups based on a selected
threshold value c. After such a rule is identified, it would be important to examine the
survival probability for patients assigned into the good or poor prognosis groups. Such
probabilities are often summarized based on the positive predictive values (PPV) and neg-
ative predictive values (NPV), defined as
PPVt0,τ (c) = prΩt0 (D
t0+τ
L = 1 | Zη > c), and NPVt0,τ (c) = prΩt0 (D
t0+τ
L = 0 | Zη ≤ c).
3. Developing Conditional Prognostic Rules
3.1. Models for constructing a composite score
When TL = TS, various standard survival models could be used for constructing composite
scores to predict Dt0+τL among those with TS > t0. One simple approach is to employ a
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global proportional hazards (PH) model
pr(TL > t0 + τ, TS > t0 | Z) = pr(TL > t0 + τ | Z) = exp {−Λ0(t0 + τ) exp(βT0Z)} (1)
where Λ0(·) is an unspecified baseline cumulative hazard function and β0 is the unknown
covariate effect. Under model (1), the conditional survival probability is
prΩt0 (TL > t0 + τ | Z) = prΩt0 (R
t0
L > τ | Z) = exp {−Λt0(τ) exp(βT0Z)}
where Λt0(τ) = Λ0(t0 + τ)− Λ0(t0). This, together with the arguments given in McIntosh
and Pepe (2002), implies that under the PH model, βT0Z is the optimal composite score for
classifying Dt0+τL among Ωt0 , for any given t0 and τ . Here, the optimality is with respect
to the ROC curve ROCt0,τ (·). This, together with the consistency of the maximum partial
likelihood estimator of β0, β̂, the estimated risk score β̂
T
Z is the optimal score for predicting
Dt0+τL asymptotically.
In general, when TS and TL represent survival times for two different outcomes, various
bivariate survival models could be considered to construct an optimal score for the prediction
of the residual life Rt0L . Existing inference procedures for such conditional survival models
are often derived based on joint inference on bivariate survival via bivariate copula or frailty
modeling frameworks (Shih and Louis, 1995; Klaassen and Wellner, 1997; Oakes and Ritz,
2000; Pitt et al., 2006; Hougaard, 1995; Ha et al., 2001; Cai et al., 2002; Zeng and Lin,
2007). However, when the fitted model fails to hold, these procedures may not perform
well yielding unstable prediction rules with poor predictive accuracy. To overcome such
difficulties, we propose to construct time specific scores for any given t0 and τ of interest.
In particular, we propose to fit a conditional proportional hazards working model for the
residual life Rt0L among Ωt0 :
prΩt0 (R
t0
L > τ | Z) = exp
{
−Λt00 (τ) exp(β¯Tt0Z)
}
(2)
where Λt00 (·) is the unspecified baseline cumulative hazard function among Ωt0 and β¯t0 is the
unknown covariate effect. When the model (2) holds, arguments as given above can be used
to show that the binary classification rule I(Zη > c) where Zη = exp
{
−Λt00 (τ) exp(β¯Tt0Z)
}
has the optimal limiting ROC curve for classifying Dt0+τL among Ωt0 . Note that model (2)
includes the global Cox model (1) as a special case when TL = TS.
3.2. Inference Procedures for Model Parameters and Accuracy Measures
Due to censoring and competing risks, one may not observe TL or T ∗S directly. In the
presence of competing risks, the short term outcome T ∗S such as distant metastasis may not
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be observable if TL corresponds to a terminal event such as death. However, we assume
that TL is only subject to non-informative censoring, i.e. TL will not be censored by T ∗S .
Under such assumptions, both TL and TS = min(T ∗S , TL) are only subject to independent
censoring. Thus for Tι, we observe Xι = min(Tι, C), δι = I(Tι ≤ C), for ι = S, L, where
C is time of censoring. We assume that C is independent of (TL, TS) and Z with a common
survival function G(t) = pr(C ≥ t). Suppose data for analysis consist of n independent and
identically distributed random vectors {(XLi, δLi, , XSi, δSi,Zi), i = 1, ..., n}.
To estimate β¯t0 , we use the subgroup with XS ≥ t0 as an unbiased random sample for
the subpopulation Ωt0 since pr(TL ≤ t0 + τ,Z ≤ z | XS ≥ t0) = prΩt0 (Rt0L ≤ τ,Z ≤ z).
It follows that β¯t0 can be estimated by maximizing the partial likelihood function using
subjects with XS ≥ t0. Specifically, we propose to obtain β̂t0 as the maximizer of
̂`
t0(β) =
∑
i:XSi≥t0
∫ ∞
t0
βTZi − log
 ∑
j:XSj>t0
exp{βTZj}I(XLj ≥ s)

 dNi(s) (3)
where Ni(s) = I(XLi ≤ s)δLi. In Appendix A, we show that β̂t0 → βt0 in probability
as n → ∞ regardless of the adequacy of (2), where βt0 is the unique maximizer of the
limiting objective function, `t0(β). Furthermore, we show that
√
n(β̂t0 − βt0) converges in
distribution to a multivariate normal with mean zero.
To evaluate our prediction rule, we propose the following estimators for the aforemen-
tioned accuracy measures using inverse probability weighting. Specifically, let
Ŝenst0,τ (c) =
∑
i:XSi>t0 ŴiI(β̂
T
t0Zi ≥ c)I(XLi ≤ t0 + τ)∑
i:XSi>t0 ŴiI(XLi ≤ t0 + τ)
Ŝpect0,τ (c) =
∑
i:XSi>t0 ŴiI(β̂
T
t0Zi < c)I(XLi > t0 + τ)∑
i:XSi>t0 ŴiI(XLi > t0 + τ)
P̂PVt0,τ (c) =
∑
i:XSi>t0 ŴiI(β̂
T
t0Zi ≥ c)I(XLi ≤ t0 + τ)∑
i:XSi>t0 ŴiI(β̂
T
t0Zi ≥ c)
N̂PVt0,τ (c) =
∑
i:XSi>t0 ŴiI(β̂
T
t0Zi < c)I(XLi > t0 + τ)∑
i:XSi>t0 ŴiI(β̂
T
t0Zi < c)
.
where Ŵi =
I(XLi>t0+τ)bG(t0+τ) + I(XLi≤t0+τ)δLibG(XLi) and Ĝ(·) is the Kaplan-Meier estimator of G(·).
Subsequently, ROCt0,τ (u) can be estimated as R̂OCt0,τ (u) = Ŝenst0,τ{Ŝpec
−1
t0,τ (1−u). Sim-
ilarly, AUCt0,τ can be estimated by
ÂUCt0,τ =
∑
i:XSi>t0,XLi≤t0+τ
∑
j:XSj>t0,XLj>t0+τ I(β̂
T
t0Zi > β̂
T
t0Zj)ŴiŴj∑
i:XSi>t0,XLi≤t0+τ
∑
j:XSj>t0,XLj>t0+τ ŴiŴj
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In Appendix B we show that the accuracy functions are consistent for the theoretical coun-
terparts, uniformly in (c, t0, τ). Furthermore, we show that
√
n(Ŝenst0,τ (c) − Senst0,τ (c))
converges weakly to a zero-mean Gaussian processes. Similarly, this holds for the other
accuracy measures and it is not difficult to show that these convergences hold jointly. It
then follows from the stochastic equi-continuity of these processes that
√
n{R̂OCt0,τ (u) −
ROCt0,τ (u)} also converges weakly to a Gaussian process. Similar weak convergence re-
sults for other measures with cut-off values selected to achieve a sensitivity level of u, e.g.
P̂PVt0,τ{Sens−1t0,τ (u)}.
However, it is difficult to empirically estimate the variance associated with these pro-
cesses as they involve derivative functions that are difficult to estimate especially under
model mis-specification. To overcome such difficulties, we propose using a perturbation-
resampling method (Park and Wei, 2003; Cai et al., 2005; Tian et al., 2007) to approxi-
mate the distributions of the proposed estimators. In particular, let {V (b)i , i = 1, ..., n, b =
1, ..., B} be nB independent realizations of a positive random variable V from a known
distribution with unit mean and unit variance. Let β̂
(b)
t0 be the minimizer of
̂`(b)
t0 (β) =∑
i:XSi>t0 [
∫ {βTZi−log∑j:XSj>t0 V (b)j exp{βTZj}I(XLj ≥ s)}V (b)i dNi(s)]. For accuracy mea-
sures such as AUCt0,τ and Senst0,τ (c), let
ÂUC
(b)
t0,τ =
∑
i:XSi>t0,XLi≤t0+τ
∑
j:XSj>t0,XLj>t0+τ I(Z
T
i β̂
(b)
> ZTjβ̂
(b)
)Ŵ (b)i Ŵ
(b)
j V
(b)
i V
(b)
j∑
i:XSi>t0,XLi≤t0+τ
∑
j:XSj>t0,XLj>t0+τ Ŵ
(b)
i Ŵ
(b)
j V
(b)
i V
(b)
j
Ŝens
(b)
t0,τ (c) =
∑
i:XSi>t0,XLi≤t0+τ Ŵ
(b)
i I(Z
T
i β̂
(b)
t0 ≥ c)V (b)i∑
i:XSi>t0,XLi≤t0+τ Ŵ
(b)
i V
(b)
i
where Ŵ (b)i = I(XLi > t0 + τ)/Ĝ
(b)(t0 + τ) + I(XLi ≤ t0 + τ)δLi/Ĝ(b)(XLi) and Ĝ(b) is
the Kaplan-Meier estimator of G(·) with weights V (b)i . The empirical distributions of these
realizations can be used to approximate the distribution of the corresponding estimators.
For example, the variance of ÂUCt0,τ can be estimated using
σ̂2t0,τ = B
−1
B∑
b=1
{ÂUC(b)t0,τ − ÂUCt0,τ}2.
A 100(1−2α)% confidence interval (CI) for AUCt0,τ could be obtained either using the nor-
mal CI or the empirical quantiles of the perturbed samples. The validity of the resampling
procedure can be justified based on the large sample theory given in Appendix B along with
similar arguments as given in Cai et al. (2005).
The aforementioned accuracy estimators, commonly referred to as apparent accuracy
estimates, tend to be overly optimistic, particularly when the dimension of Z is not small.
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To reduce this potential bias, we consider a general cross-validation where we randomly
split the data into a training set of size nt and a validation set of size nv = n− nt. For the
kth split, we estimate βt0 using the training set, denoted by β̂
(CV)k
t0 . Then for any accuracy
measure of interest, say AUCt0,τ , we estimate the AUC for the linear score β̂
(CV)kT
t0 Z based on
the validation set, denoted by ÂUC
(CV)k
t0,τ . Let ÂUC
(CV)
t0,τ be the average of all ÂUC
(CV)k
t0,τ over
K random splits. Using similar justification as given by Tian et al. (2007) and Uno et al.
(2007), it can be shown that ÂUC
(CV)
t0,τ and ÂUCt0,τ have the same limiting distribution at
the first order. Therefore, one may construct a 95% CI for AUCt0,τ as ÂUC
(CV)
t0,τ ± 1.96σ̂t0,τ .
It is important to note that our proposed method holds for any choice of t0 and τ . In
practice, one may consider the proposed estimator across a range of t0 and τ as a basis
for selecting an appropriate time point such that the prediction model is most accurate.
For example, suppose t0 is pre-selected by a clinician, such as a regularly scheduled 1-year
appointment. Information guiding the choice of τ would be a clinically meaningful as it
would shed light on what time point/period Z is most useful in prediction. To determine
the values of τ that offer high overall accuracy from classifying Dt0+τL for a fixed t0, one
may plot ÂUC
(CV)
t0,τj over a range of τj in some interval [τl, τr] ⊂ (t0,max(XLi)) and con-
struct both point-wise and simultaneous CIs using the perturbation-resampling method as
described above. A 100(1 − α)% simultaneous CI for {ÂUC(CV)t0,τj , τj ∈ [τl, τr]} can be ob-
tained as {ÂUC(CV)t0,τj ± ĉασ̂t0,τ , τj ∈ [τl, τr]}, where ĉα is the (1 − α) empirical quantile of
{supτj∈[τl,τr]|ÂUC
(b)
t0,τj−ÂUCt0,τj |/σ̂t0,τj , b = 1, ..., B}. The simultaneous CI will ensure the
control of family-wise type I error when selecting a set of τj ’s such that the overall accuracy
is above a certain threshold value.
3.3. Incremental Value of New Markers
Determining the incremental value (IV) of new markers in prediction is often of clinical
interest, particularly if measuring the markers is expensive or invasive. Several procedures
have been developed to quantify the overall IV from a new marker for the entire population
(Tian et al., 2007; Uno et al., 2007; Pepe et al., 2004, 2008; Pencina et al., 2008). Our pro-
posed method could potentially shed light on how the IV may vary across sub-populations.
For example, if the new marker is only useful for predicting TL among those with good
prognosis, one may expect that the IV is near zero for predicting TS ≥ t0, but is high for
predicting TL < t0 + τ among those with TS > t0. This may provide a useful tool for prac-
titioners to decide when the new marker is needed in addition to conventional risk factors.
Let (M1) denote the model with routine markers only and (M2) denote the model with both
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routine markers and the new markers. One may quantify the IV of the new markers based
on ∆t0,τ = AUC
(M2)
t0,τ −AUC(M1)t0,τ , where AUC(Mk)t0,τ denotes the AUC of (Mk), for k = 1, 2. To
make inference about ∆t0,τ , let ÂUC
(CV)(Mk)
t0,τ denote the cross-validated estimate of AUC
(Mk)
t0,τ
and {ÂUC(Mk)(b)t0,τ , b = 1, ..., B} be the perturbed estimates of AUC(Mk)t0,τ . Then one may make
inference about ∆t0,τ based on ∆ˆ
(CV)
t0,τ = ÂUC
(CV)(M2)
t0,τ − ÂUC
(CV)(M1)
t0,τ and the empirical vari-
ance of {B−1∑ni=1{ÂUC(M2)(b)t0,τ −ÂUC(M1)(b)t0,τ , b = 1, ..., B}. To examine how the IV vary over
τ , one may assess ∆t0,τ as a function of τ and identify the range of τ such that M2 is better
than M1. To this end, one may construct a plot of ∆̂
(CV)
t0,τj = ÂUC
(CV)(M2)
t0,τj − ÂUC
(CV)(M1)
t0,τj . Si-
multaneous confidence intervals for {∆t0,τj , τj ∈ [τl, τr]} could be constructed using similar
procedure as for {ÂUC(CV)t0,τj , τj ∈ [τl, τr]}.
3.4. Comprehensive Prognosis of Short Term and Long Term Outcomes
In practice, one may be interested in both the prognosis of the short term and the long term
outcomes. Our proposed procedures can easily be extended to make such joint predictions.
Let Dt0S = I(TS ≤ t0) denote the status of the short term outcome. When the underlying
patient population consists of a mixture of short term survivors and long term survivors,
the optimal prediction score for short term outcomes may be different from that of long
term outcomes. Thus, to construct a robust prediction rule for Dt0S , one may fit a separate
Cox model using survival information on TS up to t0 as in Cai et al. (2010). Let α̂t0 denote
the maximum partial likelihood estimator for the effect of Z on TS based on the truncated
data {(XSi ∧ t0, δSiI(XSi ≤ t0),Zi), i = 1, ..., n}. Such a fitting essentially corresponds to
assuming the Cox model holds up to t0. For future subjects with outcomes (T 0S , T
0
L ) and
covariate level Z0, we will classify them as having a poor short term prognosis, denoted by
S+t0 , if α̂
T
t0Z
0 > ĉSt0 , and good short term prognosis, denoted by S
−
t0 , otherwise. Similarly, for
the long term conditional survival, we classify subjects as having a poor prognosis, denoted
by Lτ+t0 , if β̂
T
t0Z
0 > ĉLτt0
, and good prognosis, denoted Lτ−t0 , otherwise. Here ĉSt0 and ĉLτt0
are the cut-off values selected to achieve certain desired sensitivity or specificity levels for
the classification of the corresponding events.
To illustrate how the proposed procedures may be useful in clinical practice, we next
describe how a clinician may provide a two-step prognosis for future subjects. For future
patients with Z0, the clinician will first classify them as either S+t0 or S
−
t0 and provide their
chance of surviving to t0 given their prognosis based on pr(T 0S > t0 | S−t0) and pr(T 0S > t0 |
S+t0). In the next step, the clinician will further classify subjects as having a good or poor
conditional prognosis and inform them regarding their chance of surviving an additional τ
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years after t0 provided that they do survive t0 years i.e. T 0S > t0. This information would
be based on prΩt0 (T
0
L > τ + t0|St0 ,Lτt0 ), for  = + and −. These conditional probabilities
can be estimated non-parametrically via IPW similar to those given in section 3.2
4. Simulations
To examine finite-sample properties of the proposed estimation procedures, we conducted
simulation studies under various scenarios and focused on the case with TL = TS = T
for simplicity. Two types of models were used to generate T : a mixture of log-normal in
setting (i) and a Cox model in setting (ii). Two types of censoring patterns were consid-
ered in setting (i) to examine the effect of censoring. The covariate vector Z consists 5
components: (Z2, Z3, Z4) ∼ N(0,Σ) with unit variance and a weak correlation ranging
from -.03 and .05; Z1 ∼ a bernoulli distribution with success probability Φ(Z2 + Z3); and
Z5 ∼ Uniform[Φ(Z4), 1 + Φ(Z4)]. In each setting, we generated 1000 realizations of size n
for n=200, 500 and 1,000 and obtained β̂t0 as well as β̂, the standard maximum partial
likelihood estimator of β under a global Cox model. Accuracy measures were also calculated
for both β estimates. Here, in addition to assessing the overall accuracy based on the AUC,
we consider the specificity, PPV and NPV at a cut-off value corresponding to a sensitivity
level of 0.90. The standard error estimates were obtained based on 500 perturbations each.
In setting (i), the survival time was generated from T = exp{(βT1Z + 1)/6} with 1 ∼
N(−3, 1) if B = 1 and T = exp{(βT0Z + 0)/6}+ 1 with 0 ∼ N(10, 4) if B = 0, where B ∼
Bernoulli(.4), β1 = (3, 6, 1.5, 0, 0)T and β0 = c(0, 0, 1.5, 3, 1.5). This mimics a clinical setting
in which (Z1, Z2, Z3) are predictive of short term survival, (Z3, Z4, Z5) are predictive of long
term survival. For illustration, we chose t0 to be year 1 to reflect an early indication of
disease and τ to be year 5. Therefore, among patients surviving 1 year, we wish to estimate
their probability of survival past year 6, given baseline covariates. Under these conditions,
pr(T ≤ t0) = .23 and pr(T ≤ τ + t0 | T > t0) = .49. We first consider the case when C was
generated from exponential with rate .11, yielding a censoring rate of approximately 40%.
The results are shown in Tables ??. Since both the global and the conditional Cox model are
mis-specified in this case, β̂t0 and β̂ are converging to two different limits. β̂t0 assigns more
weights on (Z3, Z4, Z5), the covariates that are helpful for predicting long term survival.
On the contrary, β̂ assigns more similar weights to all covariates. The resulting linear score
has a higher overall accuracy with AUCt0,τ ∼ .74 for the landmark method compared to
AUCt0,τ ∼ .67 using the global Cox model. All point estimators have negligible bias. The
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standard errors estimated from the resampling method are close to the empirical standard
errors and the empirical coverage levels are close to their nominal level.
We also considered a different setting to asses how censoring patterns effect the estima-
tion. In this setting, T was generated from the same log-normal mixture distribution as
described above. However, the censoring time was generated from a mixture of exponen-
tial(rate=.30) with probability .40 and exponential(rate =.02) with probability .60. Under
this setting, about 10% are censored within the first year and 25% are censored within the
first 6 years. As shown in Tables 2, β̂t0 and β̂ have limits different from those for the
previous setting with exponential censoring. This is due to the fact that the maximizer of
the partial likelihood function is no longer free of the censoring distribution under model
mis-specification. The accuracy of the linear scores is also slightly different for these two
settings. However, the proposed procedures remain to perform well with negligible bias in
the point estimates and proper coverage level for the interval estimates.
In setting (ii), we are interested in examining the efficiency loss due to the use of the
more robust conditional landmark model when the global Cox model holds. To this end, we
generated T from a Cox model with 1.25 log(T ) = 2 +βT0Z + , where  is from an extreme
value distribution and β0 = (1, .5, .5, 1, .5)T. Under this configuration, pr(T ≤ t0) = .20,
pr(t0 < T < τ + t0) = .33 and pr(T < τ + t0 | T > t0) = .34. Censoring time was generated
from an exponential distribution with rate .05, yielding approximately 40% of censoring.
Results shown in Tables 3. Since β̂ is semi-parametric efficient and β̂t0 is obtained based on
the subset in Ωt0 , which consists of 83% of the entire sample, there is a significant efficiency
loss due to landmarking. However, the efficiency loss in estimating the accuracy measures
is negligible.
5. Example
In this section, we illustrate our proposed procedures using a dataset originally used in van
de Vijver et al. (2002) to evaluate a 70-gene risk score for breast cancer prognosis. More
recently, Carter et al. (2006) demonstrated that a chromosome instability genetic score,
denoted by CIN25, is predictive of survival for various types of cancer. Here we investigate
the predictive ability of CIN25 for breast cancer survival using the data from van de Vijver
et al. (2002). This dataset consists of 260 women, with individual information on time
to death, time to distant metastasis, CIN25 gene score, age, tumor grade, size of tumor,
baseline lymph node status, and estrogen receptor status.
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For illustration, we first consider the case with TL = T ∗S being metastasis free survival.
There were a total of 88 events and the 5-year event rate is about 0.24. To provide a
comprehensive prediction for these patients, we first aim to make a prediction for a short
term outcome, progression-free survival by t0=3, i.e. Dt0S = I(TS ≤ 3). The 3-year event
rate was about 0.17. To construct a robust score for this prediction, we fit a Cox model
using survival information up to t0 and obtain a linear score based on such a truncated
model. For comparison, we also obtain the linear score from fitting a global Cox model.
After the prediction rule for Dt0S is developed and evaluated, we next construct and evaluate
prediction rules for 5-year progression-free survival among among those who survived 3 years
without metastasis based on our proposed landmark procedures. In Table 4(a), we present
the regression coefficients estimates for the risk scores. For the short term prediction, the
global Cox model assigns the highest weight on the gene score whereas the truncated model
assigns more weight on the tumor grade. For the landmark prediction, the conditional Cox
model also assigns the most weight on the gene score. This suggests that the gene score
may be more useful for long term prediction than for short term prediction. As shown
in Table 4(b), the risk score has a reasonable accuracy in classifying TL ≤ 3 with AUC
0.733 (s.e. 0.035) for the truncated model and 0.728 for the global Cox model. To develop a
prognostic rule for the short term survival, we select the cut-off value to achieve a sensitivity
level of 0.90 and classify patients as having good prognosis if the predicted risk of failure
is lower than the cut-off value. The rule from the truncated model leads to 24% chance of
failure among those classified as poor prognosis and 96% of survival among those with good
prognosis. Now among those who do survive 3-years without metastasis, the risk score has
lower accuracy in predicting the long term outcome with AUC 0.64 for the landmark model
and 0.63 for the global Cox model. At sensitivity level of 0.90, the landmark model yields
a rule with specificity of 0.35 (s.e. 0.11). Based on the corresponding prognostic rule, the
chance of survival is 97% for those with good long term prognosis and 77% for those with
poor prognosis.
Now, to evaluate the incremental value of the gene score, we compared the aforemen-
tioned accuracy to those obtained by fitting the models with predictors without the gene
score. For the short term outcome based on the truncated Cox model, the cross-validated
estimates of AUC are 0.73 and 0.74 with and without the gene score, respectively. This
again suggests that the gene score may not be useful for predicting short term survival. For
the landmark prediction based on the conditional Cox model, the AUC estimate decreases
from 0.64 to 0.52 when the gene score is removed from the model. A 95% confidence interval
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for difference in the AUC is (0.02,0.22) suggesting that the gene score significantly improves
the accuracy for the landmark prediction. To evaluate the IV of gene score for various
values of τ , let M2 and M1 indicate models with and without the gene score, respectively.
As shown in Figure 2, the IV of gene score slightly increases for larger values of τ and is
significant for a few τj ’s. However, after adjusting for overall type I error based on the
simultaneous band, the improvement due to the gene is no longer statistically significant.
To develop a comprehensive prognosis system, we then classify subjects as having a good
or poor prognosis for both the short term outcome and the conditional long term outcome
using all predictors. The cut-off values ĉLτt0 and ĉSt0 are selected to achieve 90% sensitivity
in classifying Dt0+τL among Ωt0 and D
t0
S , respectively. As shown in Table 4(c), the chance
of surviving 3 years without distant metastasis is 76% for those classified as S+t0 , and 96%
for those classified as S−t0 . Now, if a patient does survive 3 years without metastasis, then
her chance of surviving another 5 years is 97.7% if she is classified as (S−t0 ,L
τ−
t0 ), 83.7% if
she is classified as (S−t0 ,L
τ+
t0 ), 95.8% if she is classified as (S
+
t0 ,L
τ−
t0 ), 73.6% if she is classified
as (S+t0 ,L
τ+
t0 ).
We also consider the case with T ∗S corresponding to distant metastasis and TL being
overall survival and the goal is now prediction of 5-year overall survival among subjects
with TS = min(T ∗S , TL) > 3 years. The results are summarized in Table 5. The prediction
with both clinical and gene score has an AUC of 0.68 (se 0.048) which is slightly higher
than that for the prediction of metastasis-free survival. The global Cox method yielded
similar accuracy. The inclusion of gene score resulted in an increase of 0.09 (se 0.07) which
is similar to that of metastasis-free survival.
6. Remarks
In this article we propose robust procedures for developing and evaluating conditional prog-
nostic rules for the prediction of long term outcomes based on baseline marker and short
term outcome information in order to improve prediction accuracy for long-term survivors.
The proposed procedures yield stable prediction rules regardless of model adequacy. Such
a robustness property is particularly important when TL and TS represent two different
outcomes as for such settings, it is difficult if not impossible to identify bivariate survival
models that capture the complex relationship between the correlated outcomes and the
predictors. Under model mis-specification, traditional procedures for making inference may
not be valid and thus lead to prediction rules that are either unstable or have unsatisfac-
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tory accuracy. Furthermore, our proposed non-parametric procedures for making inference
about the accuracy measures are valid regardless of model adequacy.
It is important to emphasize that we do not require the correct specification of the
working model. In addition, the proposed procedure provides a prediction rule at baseline
using only covariate information, Z, available at baseline. If time-varying covariates are
available, it would be of interest to provide an updated prediction rule at the landmark
time t0 using covariate information collected up to t0. Our proposal can be extended by
replacing βTZi in (3) with
∫ t0
0
β(u)Zi(u)dwi(u) and parametrizing β(u) via basis function
expansions, where wi(u) is a given weight function and Zi(u) is the covariate level at time
u. Note that only covariate information collected up to t0 would be used to predict the
residual life status Dt0+τL = I(TL ≤ τ + t0) = I(Rt0L ≤ τ). This differs from the standard
Cox model with time-varying covariates, as in Kalbfleisch and Prentice (2002) (Eq. 6.14)
in which covariate information collected up to time t is used to estimate the instantaneous
hazard at time t. Details on building prediction tools and evaluation model consistency in
this setting can be found in Jewell and Nielsen (1993).
When the underlying patient population consists of a mixture of short term survivors and
long term survivors, the optimal prediction score for short term outcomes may be different
from that of long term outcomes. To provide a comprehensive system for prediction, one
may develop prognostic rules for short term survival based on robust procedures such as
fitting a truncated Cox model as in Cai et al. (2010) or time-specific generalized linear
models as in Zheng et al. (2006); Uno et al. (2007). Subsequently, the conditional prognosis
rules can be developed by fitting the proposed landmark models. Such time-specific rules
are likely to yield linear scores with higher accuracy compared to those obtained by fitting
a global Cox model. For example, under the normal mixture configuration used in the
simulation study, the ROC curves for predicting t0 survival using the truncated Cox model
vs. the global Cox model and for predicting t0 + τ survival using the landmark model vs.
the global Cox model are shown in Figure 1. The results show that both the truncated
Cox model and the landmark model give better prediction rules for t0 and t0 + τ survival,
respectively.
When TL = TS = T and T follows a Cox model, our proposed procedure remains valid
but is less efficient in estimating the regression coefficients when compared to those based
on a global Cox model. However, the efficiency loss is minimal for the estimated accuracy
measures. In practice, it is important to assess the validity of the global model and determine
whether a common risk score should be used for the prediction of both short term and long
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term outcomes. When the number of markers available for combination is not small relative
to the number of observed events, we recommend to estimate the accuracy measures based
on the cross-validation and construct confidence intervals by centering at the cross-validated
point estimate but with width determined by the resampling procedure for the apparent
error.
Appendix
Throughout, we assume that the joint density of (TL, TS,Z) is twice continuously differen-
tiable, Z are bounded, and pr(XL > t0 + τ,XS > t0) > 0, C is independent of (TL, TS,Z)
with a survival function G(·).
Appendix A: Consistency and Large Sample Properties of β̂
To establish the convergence of β̂t0 under possible model mis-specification, let Ŝ
(k)(t,β) =
n−1
∑n
i=1 exp{βTZi}Z⊗ki I(XLi ≥ t,XSi > t0), S(k)(t,β) = E{Ŝ(k)(t,β)} and
`t0(β) = E
∫ ∞
t0
[
I(XLi ≥ t0)
{
βTZi − logS(0)(t,β)
}
dNi(s)
]
,
where and for any vector a, a⊗0 = 1, a⊗1 = a and a⊗2 = aaT. It follows from similar
arguments as given by Hjort (1992) that `t0(β) is a concave function of β and thus `t0(β) has
a unique maximizer, denoted by βt0 . We assume that βt0 is an interior point of a compact
parameter space. Without censoring, it can be shown using a penalized quasi-likelihood
approximation (Breslow and Clayton, 1993) that in the neighborhood of βt0 , `t0(β) can
be approximated by the covariance between the linear score and the survival status. In
view of Theorem 2.1 of Newey et al. (1994), to show that β̂t0 is a consistent estimator of
βt0 , it suffices to show that ̂`t0(β) converges to `t0(β) uniformly in β. It follows from a
uniform law of large numbers (ULLN) (Pollard, 1990) that supt,β |Ŝ(k)(t,β)−S(k)(t,β)| →
0, in probability. This, together with another application of a ULLN, implies that ̂`t0(β)
converges to `t0(β) uniformly in β. Therefore, β̂t0 → βt0 in probability regardless the
adequacy of model (2).
To derive the limiting distribution of n
1
2 (β̂t0 − βt0), we take a Taylor series expansion
of the score function
Û(β) =
∂ ̂`t0(β)
∂β
= n−1
n∑
i=1
∫ ∞
t0
{
Zi − Ŝ
(1)(t,β)
Ŝ(0)(t,β)
}
dNi(t)I(XSi > t0)
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and obtain
0 = n
1
2 Û(βt0) + Â(β̂
∗
t0)n
1
2 (β̂t0 − βt0),
where Â(β) = ∂Û(β)/∂βT and β̂
∗
t0 satisfies ‖β̂
∗
t0 − βt0‖ ≤ ‖β̂t0 − βt0‖. First, it follows
from the uniform convergence of Ŝ(k)(t,β) and a ULLN that Â(β) → A(β) in probability
uniformly in β, where A(β) = ∂2`t0(β)/∂β∂β
T. This, together with the consistency of β̂t0
implies that Â(β̂
∗
t0)→ A(βt0) in probability.
We next derive an asymptotic expansion for n
1
2 Û(βt0). To this end, we let ξ̂(t) =
n−1
∑n
i=1Ni(t)I(XSi > t0) and ξ(t) = E{ξ̂(t)} and write
n
1
2 Û(β) = n−
1
2
∑
XSi>t0
[∫ ∞
t0
{
Zi − S
(1)(t,β)
S(0)(t,β)
}
dNi(t)
]
+ n
1
2
∫ ∞
t0
{
S(1)(t,β)
S(0)(t,β)
− Sˆ
(1)(t,β)
Sˆ(0)(t,β)
}
dξ̂(t).
By a Functional Central Limit Theorem (FCLT) (Pollard, 1990) and the uniform consistency
of Ŝ(k)(t,β),
n
1
2
{
S(1)(t,β)
S(0)(t,β)
− Sˆ
(1)(t,β)
Sˆ(0)(t,β)
}
≈ −n− 12
n∑
j=1
I(XLj ≥ t,XSj > t0) exp{βTZj}
S(0)(t,β)
{
Zj − S
(1)(t,β)
S(0)(t,β)
}
(4)
Moreover, by a ULLN, supt |ξ̂(t)−ξ(t)| → 0 in probability. This, together with (4), a strong
representation theorem (Pollard (1990)) and Lemma A.3 of Bilias et al. (1997), implies that
n
1
2
∫ ∞
t0
{
S(1)(t,β)
S(0)(t,β)
− Sˆ
(1)(t,β)
Sˆ(0)(t,β)
}
dξ̂(t) = n
1
2
∫ ∞
t0
{
S(1)(t,β)
S(0)(t,β)
− Sˆ
(1)(t,β)
Sˆ(0)(t,β)
}
dξ(t) + op(1).
This, together with the convergence of Â, implies that
n
1
2 (β̂t0 − βt0) ≈ n−
1
2
n∑
i=1
Ui(βt0). (5)
where
Ui(β) = −A(βt0)−1
∫ ∞
t0
I(XSi > t0)
{
Zi − S
(1)(t,β)
S(0)(t,β)
}{
dNi(t)− I(XLi ≥ t) exp{β
TZi}
S(0)(t,β)
dξ(t)
}
.
By a central limit theorem, n
1
2 (β̂t0−βt0) converges in distribution to a multivariate normal
with mean 0 and covariance matrix E{Ui(βt0)Ui(βt0)T}.
Appendix B: Consistency and Large Sample Properties of accuracy measures
In this section, we derive large sample properties for the estimated accuracy measures.
We only provide details for the estimated sensitivity function, but note that the same
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arguments can be used for the estimated specificity, PPV and NPV functions. To this end,
we let H(β, c) = prΩt0 (β
TZ > c | DtL = 1), Wi = I(XLi > t0 + τ)/G(t0 + τ) + I(XLi ≤
t0 + τ)ı/G(XLi),
Ĥ(β, c) =
∑n
i=1 ŴiI(β
TZi ≥ c)I(XLi ≤ t0 + τ,XSi > t0)∑n
i=1 ŴiI(XLi ≤ t0 + τ,XSi > t0)
and H˜(β, c) =
∑n
i=1WiI(β
TZi ≥ c)I(XLi ≤ t0 + τ,XSi > t0)∑n
i=1WiI(XLi ≤ t0 + τ,XSi > t0)
To establish the uniform consistency of the estimated sensitivity function, i.e. supc∈[cl,cr] |Ĥ(β̂t0 , c)−
H(βt0 , c)| → 0 in probability, we first show that supβ,c |Ĥ(β, c)− H˜(β, c)| → 0 in probabil-
ity, where 1 > H(βt0 , cl) > H(βt0 , cr) > 0. Here and in the sequel, the sup or inf is taken
over Ω(n)βt0
= {β : β = βt0 + Op(n−
1
2 )} for β and over [cl, cr] for c. It is straightforward to
see that
|Ĥ(β, c)− H˜(β, c)| ≤ |N̂ (β, c)− N˜ (β, c)|D̂(β, c) +
|D̂(β, c)− D˜(β, c)|
G(t0 + τ)D̂(β, c)D˜(β, c)
where
N˜ (β, c) = n−1
n∑
i=1
WiI(βTZi ≥ c)I(XLi ≤ t0 + τ,XSi > t0), D˜(β, c) = n−1
n∑
i=1
WiI(XLi ≤ t0 + τ,XSi > t0),
N̂ (β, c) = n−1
n∑
i=1
ŴiI(βTZi ≥ c)I(XLi ≤ t0 + τ,XSi > t0), D̂(β, c) = n−1
n∑
i=1
ŴiI(XLi ≤ t0 + τ,XSi > t0)
Furthermore,
N̂ (β, c)− N˜ (β, c) =
∫ [
1
Ĝ(s)
− 1
G(s)
]
d
{
n−1
n∑
i=1
I(βTZi ≥ c, t0 < XLi ≤ s,XSi > t0, δLi = 1)
}
It follows from the uniform consistency of Ĝ(·) (Fleming and Harrington, 1991), a uniform
law of large numbers, along with Lemma A.3 of Bilias et al. (1997) that supβ,c |N̂ (β, c) −
N˜ (β, c)| → 0 in probability. Similarly, supβ,c |D̂(β, c) − D˜(β, c)| → 0 in probability.
This, together with supβ,c |D˜(β, c) − E{D˜(β, c)}| → 0 in probability by a ULLN and and
infβ,cE{D˜(β, c)} > 0, implies the uniform in probability convergence of Ĥ(β, c)−H˜(β, c)→
0. On the other hand, by a ULLN, supβ,c |H˜(β, c)−H(β, c)| → 0, in probability. This, to-
gether with the consistency of β̂t0 , implies the uniform consistency of Ŝenst0,τ (c) = Ĥ(β̂t0 , c)
for Senst0,τ (c) = H(βt0 , c).
We now approximate the distribution of Ŵ(c) = n 12 {Ĥ(β̂t0 , c)−H(βt0 , c)} = n
1
2 {q0q̂1(β̂t0 , Ĝ)−
q1(βt0)q̂0(Ĝ)}/{q0q̂0(Ĝ)}, where q0 = pr(XLi ≤ t0+τ,XSi > t0), q̂1(β, G) = n−1
∑n
i=1 δLiI(β
TZi ≥
c,XLi ≤ t0 + τ,XSi > t0)/G(XLi), q1(β) = pr(XLi ≤ t0 + τ,XSi > t0,βTZi ≥ c) and
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q̂0(G) = n−1
∑n
i=1 δLiI(XLi ≤ t0 + τ,XSi > t0)/G(XLi). We begin by examining the numer-
ator and write n
1
2 {q0q̂1(β̂t0 , Ĝ)− q1(βt0)q̂0(Ĝ)} = (B1) + (B2) + (B3) + (B4), where
(B1) = n
1
2
[
q̂1(βt0 , G)q0 − q̂0(G)q1(βt0)
]
, (B2) = n
1
2
[
q̂1(β̂t0 , Ĝ)− q̂1(βt0 , Ĝ)
]
q0,
(B3) = −n 12
[
q̂0(Ĝ)− q̂0(G)
]
q1(βt0), (B4) = n
1
2
[
q̂1(βt0 , Ĝ)− q̂1(βt0 , G)
]
q0.
It is straightforward to show that (B1) = n−
1
2
∑n
i=1B1i(c), where B1i(c) = δLiI(XLi ≤
t0 + τ,XSi > t0){I(βTt0Zi ≥ c)q0 − q1(βt0)}/G(XLi). For (B2), we write q̂1(β, Ĝ) =∫ t0+τ
t0
η̂1(dt, c,β)/Ĝ(t), where η̂1(t, c,β) = n−1
∑n
i=1 I(XLi ≤ t,XSi > t0)I(βTt0Zi ≥ c)δLi. It
follows from a FCLT that n
1
2 (η̂1(t, c,β)−η1(t, c,β)) converges weakly to a zero-mean Gaus-
sian Process in (t, c,β) and thus is equicontinuous, where η1(t, c,β) = E{η̂1(t, c,β)}. This,
together with the uniform consistency of Ĝ, Lemma A.3 of Bilias et al. (1997), and a Tay-
lor series expansion, implies that (B2) ≈ q0n 12 (β̂ − βt0)T
∫ t0+τ
t0
G(t)−1η˙1(dt, c,βt0), where
η˙1(t, c,β) = ∂η1(t, c,β)/∂β. This, together with (5), implies that (B2) ≈ n−
1
2
∑n
i=1B2i,
where B2i(c) = q0
∫ t0+τ
t0
G(t)−1η˙1(dt, c,βt0)
TUi(βt0).
To account for the variability due to Ĝ in (B3), we first note that n
1
2 {G(t)/Ĝ(t) −
1} ≈ n− 12 ∑ni=1 UGi(t) (Fleming and Harrington, 1991), where UGi(t) = ∫ t0 dMCi(s)/piS(s),
piS(s) = pr(XLi > s), MCi(s) = I(XLi ≤ s, δLi = 0) +
∫ t
0
I(XLj > s)d log{G(s)}. This,
together with a Strong Representation Theorem (Pollard, 1990) and Lemma A.3 of Bilias
et al. (1997), implies that (B3) ≈ q1(βt0)
∫ t0+τ
t0
n
1
2 {G(t)/Ĝ(t) − 1}pr(TL ≤ dt,XS > t0) ≈
n−
1
2
∑n
i=1B3i, where B3i = q1(βt0)
∫ t0+τ
t0
UGi(t)pr(TL ≤ dt,XS > t0). Similarly, we have
(B4) = n−
1
2n−1
∑n
i=1B4i(c), where B4i(c) = q0
∫ t0+τ
t0
UGi(t)pr(TL ≤ dt,XS > t0,βTt0Z > c).
Combining the above expansions for (B1), (B2), (B3) and (B4), we have
Ŵ(c) ≈ {q0q̂0(Ĝ)}−1n− 12
n∑
i=1
{B1i(c) +B2i(c) +B3i +B4i(c)} .
On the other hand, it follows from the uniform consistency of Ĝ, a ULLN Lemma A.3 of Bil-
ias et al. (1997), that q̂0(Ĝ)→ q0. Therefore, Ŵ(c) ≈ n− 12
∑n
i=1 USensi(c), where USensi(c) =
q−20 {B1i(c) + B2i(c) + B3i + B4i(c)}. It then follows from a FCLT that Ŵ(c) converges
weakly to a mean-zero Gaussian process with covariance function cov{USensi(c), USensi(c′)}.
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Table 1. Regression parameter and accuracy measure estimates under the log-normal
mixture model for T and exponential model for C using the proposed landmark
method (Land) vs. the global Cox method (Cox), with corresponding empirical stan-
dard errors (ESE), average of the standard error estimates from the perturbation-
resampling method (ASE), and empirical coverage levels (Coverage)
(a) Regression Coefficients
n=200
Truth Average ESE ASE Coverage
Land Cox Land Cox Land Cox Land Cox Land Cox
β1 0.412 -0.184 0.433 -0.173 0.352 0.265 0.331 0.250 0.928 0.944
β2 0.047 -0.408 0.060 -0.434 0.143 0.120 0.132 0.111 0.936 0.939
β3 -0.381 -0.444 -0.369 -0.448 0.156 0.118 0.142 0.113 0.934 0.944
β4 -0.733 -0.676 -0.729 -0.669 0.196 0.132 0.178 0.136 0.927 0.957
β5 -0.382 -0.381 -0.375 -0.365 0.413 0.316 0.411 0.324 0.951 0.961
n=500
β1 0.412 -0.184 0.405 -0.176 0.205 0.157 0.202 0.155 0.950 0.936
β2 0.047 -0.408 0.052 -0.425 0.084 0.070 0.081 0.069 0.943 0.941
β3 -0.381 -0.444 -0.379 -0.449 0.090 0.072 0.087 0.069 0.941 0.951
β4 -0.733 -0.676 -0.732 -0.659 0.113 0.086 0.109 0.083 0.928 0.946
β5 -0.382 -0.381 -0.392 -0.390 0.256 0.202 0.248 0.199 0.943 0.945
n=1000
β1 0.412 -0.184 0.413 -0.174 0.140 0.108 0.141 0.108 0.943 0.949
β2 0.047 -0.408 0.051 -0.414 0.058 0.048 0.057 0.048 0.937 0.944
β3 -0.381 -0.444 -0.380 -0.445 0.062 0.048 0.061 0.049 0.940 0.958
β4 -0.733 -0.676 -0.728 -0.675 0.079 0.059 0.076 0.058 0.946 0.946
β5 -0.382 -0.381 -0.391 -0.381 0.181 0.141 0.174 0.139 0.939 0.943
(b) Accuracy Measures
n=200
Truth Average ESE ASE Coverage
Land Cox Land Cox Land Cox Land Cox Land Cox
AUC 0.741 0.668 0.756 0.675 0.051 0.067 0.048 0.064 0.891 0.920
Spec 0.319 0.207 0.360 0.243 0.119 0.106 0.129 0.117 0.952 0.960
NPV 0.771 0.686 0.790 0.707 0.074 0.114 0.078 0.120 0.885 0.892
PPV 0.557 0.519 0.577 0.535 0.067 0.059 0.072 0.065 0.952 0.962
n=500
AUC 0.741 0.668 0.746 0.671 0.031 0.041 0.031 0.041 0.937 0.946
Spec 0.319 0.207 0.336 0.223 0.074 0.065 0.081 0.071 0.954 0.960
NPV 0.771 0.686 0.779 0.696 0.046 0.071 0.050 0.075 0.931 0.931
PPV 0.557 0.519 0.565 0.526 0.042 0.038 0.044 0.040 0.958 0.960
n=1000
AUC 0.741 0.668 0.744 0.671 0.023 0.030 0.022 0.029 0.942 0.937
Spec 0.319 0.207 0.329 0.216 0.055 0.046 0.057 0.049 0.958 0.958
NPV 0.771 0.686 0.775 0.691 0.034 0.051 0.035 0.052 0.922 0.923
PPV 0.557 0.519 0.561 0.522 0.030 0.026 0.031 0.027 0.957 0.963
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Table 2. Regression parameter and accuracy measure estimates under the log-normal
mixture model for T and exponential mixture model for C using the proposed land-
mark method (Land) vs. the global Cox method (Cox), with corresponding em-
pirical standard errors (ESE), average of the standard error estimates from the
perturbation-resampling method (ASE), and empirical coverage levels (Coverage)
(a) Regression Coefficients
n=200
Truth Average ESE ASE Coverage
Land Cox Land Cox Land Cox Land Cox Land Cox
β1 0.320 -0.129 0.344 -0.104 0.285 0.229 0.274 0.221 0.943 0.939
β2 0.041 -0.298 0.039 -0.346 0.123 0.102 0.111 0.097 0.921 0.935
β3 -0.392 -0.444 -0.392 -0.448 0.127 0.103 0.120 0.099 0.933 0.943
β4 -0.764 -0.735 -0.770 -0.734 0.168 0.126 0.151 0.122 0.922 0.950
β5 -0.397 -0.396 -0.366 -0.361 0.371 0.293 0.345 0.285 0.933 0.947
n=500
β1 0.320 -0.129 0.328 -0.121 0.177 0.138 0.169 0.137 0.936 0.946
β2 0.041 -0.298 0.046 -0.313 0.077 0.060 0.069 0.060 0.916 0.942
β3 -0.392 -0.444 -0.387 -0.445 0.078 0.064 0.074 0.061 0.931 0.938
β4 -0.764 -0.735 -0.770 -0.734 0.098 0.079 0.093 0.075 0.937 0.926
β5 -0.397 -0.396 -0.384 -0.388 0.219 0.180 0.211 0.175 0.942 0.938
n=1000
β1 0.320 -0.129 0.320 -0.125 0.118 0.096 0.119 0.096 0.959 0.948
β2 0.041 -0.298 0.044 -0.307 0.052 0.043 0.049 0.042 0.937 0.946
β3 -0.392 -0.444 -0.391 -0.444 0.053 0.043 0.052 0.043 0.944 0.942
β4 -0.764 -0.735 -0.764 -0.733 0.070 0.054 0.066 0.053 0.926 0.942
β5 -0.397 -0.396 -0.398 -0.394 0.149 0.124 0.149 0.123 0.952 0.942
(b) Accuracy Measures
n=200
Truth Average ESE ASE Coverage
Land Cox Land Cox Land Cox Land Cox Land Cox
AUC 0.739 0.691 0.749 0.694 0.046 0.055 0.045 0.056 0.923 0.948
Spec 0.311 0.223 0.342 0.254 0.110 0.098 0.119 0.112 0.952 0.973
NPV 0.766 0.701 0.780 0.719 0.072 0.097 0.077 0.108 0.918 0.916
PPV 0.553 0.523 0.571 0.539 0.062 0.055 0.066 0.061 0.949 0.958
n=500
AUC 0.739 0.691 0.743 0.692 0.030 0.036 0.029 0.036 0.932 0.939
Spec 0.311 0.223 0.322 0.232 0.070 0.062 0.075 0.069 0.959 0.962
NPV 0.766 0.701 0.773 0.707 0.045 0.063 0.049 0.069 0.933 0.939
PPV 0.553 0.523 0.558 0.526 0.040 0.036 0.041 0.038 0.948 0.959
n=1000
AUC 0.739 0.691 0.742 0.692 0.021 0.025 0.021 0.025 0.944 0.949
Spec 0.311 0.223 0.317 0.231 0.052 0.045 0.053 0.048 0.945 0.955
NPV 0.766 0.701 0.769 0.706 0.033 0.045 0.034 0.048 0.927 0.938
PPV 0.553 0.523 0.557 0.527 0.029 0.026 0.029 0.026 0.947 0.948
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Table 3. Regression parameter and accuracy measure estimates under the Cox model
for T using the proposed landmark method (Land) vs. the global Cox method (Cox),
with corresponding empirical standard errors (ESE), average of the standard error
estimates from the perturbation-resampling method (ASE), and empirical coverage
levels (Coverage)
n=200
Truth Average ESE ASE Coverage
Land Cox Land Cox Land Cox Land Cox Land Cox
β1 -0.603 -0.603 -0.605 -0.605 0.296 0.271 0.283 0.257 0.932 0.931
β2 -0.301 -0.302 -0.301 -0.302 0.137 0.121 0.132 0.115 0.940 0.937
β3 -0.301 -0.302 -0.298 -0.298 0.135 0.115 0.131 0.114 0.940 0.946
β4 -0.603 -0.603 -0.603 -0.604 0.181 0.157 0.172 0.147 0.935 0.927
β5 -0.302 -0.302 -0.301 -0.299 0.379 0.330 0.361 0.319 0.935 0.928
n=500
β1 -0.603 -0.603 -0.604 -0.604 0.182 0.166 0.172 0.158 0.931 0.944
β2 -0.301 -0.302 -0.302 -0.303 0.083 0.075 0.080 0.071 0.937 0.930
β3 -0.301 -0.302 -0.301 -0.301 0.084 0.074 0.080 0.070 0.939 0.931
β4 -0.603 -0.603 -0.604 -0.603 0.113 0.097 0.105 0.090 0.925 0.921
β5 -0.302 -0.302 -0.298 -0.299 0.231 0.202 0.221 0.197 0.936 0.947
n=1000
β1 -0.603 -0.603 -0.605 -0.604 0.121 0.113 0.121 0.111 0.946 0.941
β2 -0.301 -0.302 -0.302 -0.302 0.057 0.051 0.056 0.050 0.948 0.942
β3 -0.301 -0.302 -0.300 -0.300 0.058 0.051 0.056 0.050 0.947 0.950
β4 -0.603 -0.603 -0.602 -0.602 0.077 0.066 0.074 0.063 0.936 0.932
β5 -0.302 -0.302 -0.301 -0.301 0.159 0.142 0.156 0.139 0.937 0.941
(b) Accuracy Measures
n=200
Truth Average ESE ASE Coverage
Land Cox Land Cox Land Cox Land Cox Land Cox
AUC 0.865 0.865 0.870 0.869 0.030 0.030 0.029 0.030 0.910 0.915
Spec 0.588 0.588 0.601 0.599 0.102 0.102 0.112 0.112 0.931 0.935
NPV 0.907 0.907 0.914 0.914 0.021 0.021 0.024 0.025 0.921 0.927
PPV 0.568 0.568 0.584 0.582 0.074 0.074 0.080 0.080 0.951 0.949
n=500
AUC 0.865 0.865 0.867 0.866 0.019 0.019 0.019 0.019 0.946 0.947
Spec 0.588 0.588 0.591 0.591 0.066 0.067 0.073 0.073 0.956 0.960
NPV 0.907 0.907 0.910 0.910 0.013 0.013 0.015 0.015 0.929 0.940
PPV 0.568 0.568 0.573 0.573 0.047 0.047 0.051 0.051 0.959 0.961
n=1000
AUC 0.865 0.865 0.866 0.866 0.013 0.013 0.014 0.014 0.959 0.960
Spec 0.588 0.588 0.588 0.587 0.046 0.046 0.051 0.051 0.953 0.955
NPV 0.907 0.907 0.908 0.908 0.010 0.009 0.010 0.010 0.947 0.950
PPV 0.568 0.568 0.569 0.569 0.033 0.033 0.036 0.036 0.965 0.956
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Table 4. Estimates of the regression coefficient along with the accuracy of the re-
sulting prognosis rules based on truncated Cox model for predicting Dt0S (Trunc),
the global Cox model (Cox), as well as the landmark procedure (Land) for the pre-
diction of Dt0+τL | TS > t0, where both TS and TL represent metastasis free survival.
Shown also are the standard error (SE) estimates based on the proposed resampling
methods. The regression coefficients are normalized such that ‖~β‖ = 1.
(a) Regression Coefficients
with gene score without gene score
Estimate SE Estimate SE
Dt0S Trunc Cox Trunc Cox Trunc Cox Trunc Cox
genescore 0.495 0.928 0.322 0.200
age -0.061 -0.093 0.028 0.020 -0.050 -0.099 0.027 0.020
grade 0.860 0.324 0.343 0.175 0.944 0.827 0.303 0.151
size 0.030 0.038 0.017 0.013 0.026 0.041 0.016 0.012
ERstatus -0.009 0.153 0.437 0.311 -0.283 -0.520 0.363 0.272
posLN 0.102 -0.020 0.334 0.228 0.160 0.188 0.328 0.224
Dt0+τL Land Cox Land Cox Land Cox Land Cox
genescore 0.897 0.928 0.234 0.200
age -0.072 -0.093 0.026 0.020 -0.225 -0.099 0.026 0.020
grade -0.200 0.324 0.215 0.175 0.599 0.827 0.182 0.151
size 0.022 0.038 0.018 0.013 0.067 0.041 0.017 0.012
ERstatus 0.357 0.153 0.431 0.311 -0.746 -0.520 0.383 0.272
posLN -0.147 -0.020 0.290 0.228 0.171 0.188 0.286 0.224
(b) Estimates of accuracy measures along with their standard errors (SE).
with gene score without gene score
Estimate SE Estimate SE
Dt0S Trunc Cox Trunc Cox Trunc Cox Trunc Cox
AP CV AP CV AP CV AP CV
AUC 0.770 0.733 0.754 0.728 0.035 0.057 0.761 0.730 0.755 0.730 0.039 0.057
Spec 0.451 0.396 0.428 0.375 0.109 0.112 0.456 0.400 0.433 0.390 0.156 0.101
NPV 0.961 0.955 0.959 0.956 0.011 0.020 0.961 0.945 0.959 0.948 0.032 0.037
PPV 0.243 0.239 0.235 0.234 0.049 0.051 0.244 0.242 0.236 0.238 0.058 0.039
Dt0+τL Land Cox Land Cox Land Cox Land Cox
AP CV AP CV AP CV AP CV
AUC 0.716 0.646 0.655 0.635 0.052 0.057 0.624 0.536 0.581 0.560 0.061 0.057
Spec 0.455 0.363 0.337 0.353 0.112 0.112 0.248 0.230 0.238 0.233 0.104 0.101
NPV 0.972 0.974 0.953 0.984 0.015 0.020 0.934 0.956 0.925 0.954 0.038 0.037
PPV 0.257 0.231 0.218 0.231 0.058 0.051 0.197 0.198 0.193 0.199 0.043 0.039
(c) Predicted proability of survival (standard errors) for the short term outcome and
conditional survival for the long term outcome given the corresponding prognoses. .
probability of TS > t0 probability of R
t0
L > τ | TS > t0
S+t0 0.757 (0.049)
Lτ+t0 0.736 (0.058)
Lτ−t0 0.958 (0.079)
S−t0 0.961 (0.011)
Lτ+t0 0.837 (0.145)
Lτ−t0 0.977 (0.020)
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Table 5. Estimated accuracy of the prognosis rules based on the global Cox model
(Cox) and the landmark procedure (Land) in predicting Dt0+τL | TS > t0, where both
TS represents metastasis free survival and TL represents overall survival. Shown also
are the standard error (SE) estimates based on the proposed resampling methods.
with gene score without gene score
Estimate SE Estimate SE
Land Cox Land Cox Land Cox Land Cox
AP CV AP CV AP CV AP CV
AUC 0.750 0.678 0.723 0.687 0.048 0.056 0.654 0.587 0.653 0.637 0.056 0.053
Spec 0.550 0.432 0.495 0.475 0.122 0.091 0.459 0.378 0.450 0.454 0.106 0.072
NPV 0.984 1.000 0.982 1.000 0.009 0.008 0.983 0.996 0.982 0.999 0.011 0.010
PPV 0.190 0.179 0.173 0.187 0.059 0.051 0.164 0.159 0.162 0.176 0.042 0.040
Hosted by The Berkeley Electronic Press
24 Layla Parast and Tianxi Cai lparast@hsph.harvard.edu tcai@hsph.harvard.edu
0.0 0.2 0.4 0.6 0.8 1.0
0.
0
0.
2
0.
4
0.
6
0.
8
1.
0
1-Specificity
S
en
si
tiv
ity
Fig. 1. ROC curves for the prediction of (i) TL < τ + t0 among Ωt0 based on the
landmark (solid thin line) and global Cox (solid thick line) procedures and for the
prediction of (ii) TS < τ based on the truncated (dashed thin line) and global Cox
(dashed thick line) procedures.
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Fig. 2. ∆t0,τ based on ÂUC
(CV)(M2)
t0,τ − ÂUC
(CV)(M1)
t0,τ (Solid line) for fixed t0 and various
values of τwhere M2 is the model including gene score and M1 is the model not
including gene score; pointwise confidence interval (dotted lines) and simultaneous
confidence bands (dashed lines).
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